Literature DB >> 12784106

Psychoactive drugs and pilot performance: a comparison of nicotine, donepezil, and alcohol effects.

Martin S Mumenthaler1, Jerome A Yesavage, Joy L Taylor, Ruth O'Hara, Leah Friedman, Hana Lee, Helena C Kraemer.   

Abstract

The cholinergic system plays a major role in cognitive abilities that are essential to piloting an aircraft: attention, learning, and memory. In previous studies, drugs that enhance the cholinergic system through different pharmacologic mechanisms have shown beneficial effects on cognition; but dissimilar cognitive measures were used and samples were not comparable. A comparison within the same cognitive tasks, within comparable samples appears desirable. Toward this aim, we compared effect sizes (ES) of performance-enhancing doses of nicotine (a nicotinic receptor agonist) and donepezil (an acetylcholinesterase inhibitor) as found in our prior work on pilot performance. We also compared cholinergic ES to those of performance-impairing doses of alcohol. In three randomized, placebo-controlled trials, we assessed the flight performance of aircraft pilots in a Frasca 141 simulator, testing I: the acute effects of nicotine gum 2 mg; II: the effects of administration of 5 mg donepezil/day for 30 days; and III: the acute and 8 h-carryover effects of alcohol after a target peak BAC of 0.10%. We calculated the ES of nicotine, donepezil, and alcohol on a flight summary score and on four flight component scores. Compared to placebo, nicotine and donepezil significantly improved, while alcohol significantly impaired overall flight performance: ES (nicotine)=0.80; ES (donepezil)=1.02; ES (alcohol acute)=-3.66; ES (alcohol 8 h)=-0.82. Both cholinergic drugs showed the largest effects on flight tasks requiring sustained visual attention. Although the two tested cholinergic drugs have different pharmacologic mechanisms, their effects on flight performance were similar in kind and size. The beneficial effects of the cholinergic drugs on overall flight performance were large and the absolute (ie nondirectional) sizes were about one-fourth of the absolute ES of acute alcohol intoxication and roughly the same as the absolute 8 h-carryover ES of alcohol.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12784106     DOI: 10.1038/sj.npp.1300202

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  17 in total

Review 1.  Cognitive effects of nicotine: genetic moderators.

Authors:  Aryeh I Herman; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  Cognitive performance of healthy young rats following chronic donepezil administration.

Authors:  Debora Cutuli; Francesca Foti; Laura Mandolesi; Paola De Bartolo; Francesca Gelfo; Francesca Federico; Laura Petrosini
Journal:  Psychopharmacology (Berl)       Date:  2008-02-29       Impact factor: 4.530

3.  Effects of cholinesterase inhibitors on visual attention in drivers with Alzheimer disease.

Authors:  Lori A Daiello; Brian R Ott; Elena K Festa; Michael Friedman; Lindsay A Miller; William C Heindel
Journal:  J Clin Psychopharmacol       Date:  2010-06       Impact factor: 3.153

Review 4.  [Neuro-enhancement. Brain doping].

Authors:  H Förstl
Journal:  Nervenarzt       Date:  2009-07       Impact factor: 1.214

5.  How does dementia affect driving in older patients?

Authors:  Brian R Ott; Lori A Daiello
Journal:  Aging health       Date:  2010-02-01

Review 6.  [Neuroenhancement].

Authors:  G Gründer; T Bartsch
Journal:  Nervenarzt       Date:  2014-12       Impact factor: 1.214

Review 7.  Impact of Smoking and Smoking Cessation Medications in Aviators.

Authors:  Jason I Dailey; Kristopher C Wilson
Journal:  Curr Psychiatry Rep       Date:  2019-11-20       Impact factor: 5.285

8.  Variations in Acetylcholinesterase Activity within Human Cortical Pyramidal Neurons Across Age and Cognitive Trajectories.

Authors:  Monica Janeczek; Tamar Gefen; Mehrnoosh Samimi; Garam Kim; Sandra Weintraub; Eileen Bigio; Emily Rogalski; M-Marsel Mesulam; Changiz Geula
Journal:  Cereb Cortex       Date:  2018-04-01       Impact factor: 5.357

9.  Effects of nicotine and mecamylamine on cognition in rhesus monkeys.

Authors:  Simon N Katner; Sophia A Davis; Amber J Kirsten; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2004-04-27       Impact factor: 4.530

10.  Impaired cognition and attention in adults: pharmacological management strategies.

Authors:  Hervé Allain; Yvette Akwa; Lucette Lacomblez; Alain Lieury; Danièle Bentué-Ferrer
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.